Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C19H22N2O |
| Molecular Weight | 294.3908 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCCCC1(C)C(=O)N(C2=C1C=CC=C2)C3=CC=CC=C3
InChI
InChIKey=HBGWAZBZXJBYQD-UHFFFAOYSA-N
InChI=1S/C19H22N2O/c1-19(13-8-14-20-2)16-11-6-7-12-17(16)21(18(19)22)15-9-4-3-5-10-15/h3-7,9-12,20H,8,13-14H2,1-2H3
| Molecular Formula | C19H22N2O |
| Molecular Weight | 294.3908 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Amedalin (UK-3540) is a selective norepinephrine reuptake inhibitor developed in the 1970s. Amedalin was a potential antidepressant compound. It has no significant effect on reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties. This drug was never marketed.
CNS Activity
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:53 GMT 2025
by
admin
on
Mon Mar 31 18:20:53 GMT 2025
|
| Record UNII |
2OWK6X9N16
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2110769
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
DB09188
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
22136-26-1
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
31075
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
C79852
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
SUB05406MIG
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
2OWK6X9N16
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
2976
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
DTXSID40865034
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
AMEDALIN
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY | |||
|
100000087192
Created by
admin on Mon Mar 31 18:20:53 GMT 2025 , Edited by admin on Mon Mar 31 18:20:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |